QUANTITY | PRIC PER pellet | SAVE AMOUNT |
---|---|---|
10 to 19 | EUR 1.00 /pellet | 0% |
20 to 29 | EUR 0.90 /pellet | 10% |
30 to 49 | EUR 0.85 /pellet | 15% |
50 to 99 | EUR 0.75 /pellet | 25% |
100 to 249 | EUR 0.60 /pellet | 40% |
250 to 499 | EUR 0.50 /pellet | 50% |
500 + | EUR 0.35 /pellet | 65% |
POPULAR PRODUCT
Many customers bought this product recently.
Flubromazepam, a compound first synthesized in the 1960s, initially faded into obscurity due to its lack of clinical and commercial promise. However, around 2012, it resurfaced in drug detection databases as it gained traction within the designer drug community. This resurgence has sparked interest in its properties, effects, and potential applications, despite the limited formal research surrounding it.
Flubromazepam is structurally related to phenazepam, differing primarily by the substitution of a chlorine atom with a fluorine atom. This seemingly minor alteration can significantly impact the compound's pharmacokinetics, leading to faster absorption and more pronounced effects. The chemical formula for flubromazepam is 7-Bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one, and it is classified as a research chemical with a CAS number of 2647-50-9.
While flubromazepam has not been extensively studied, it is believed to operate through the traditional GABA-mediated pathway common to most benzodiazepines. By binding to the benzodiazepine receptor site, flubromazepam enhances the effects of gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the brain. This modulation results in a range of effects, including anxiolytic, muscle-relaxant, anticonvulsant, amnesic, sedative, and hypnotic properties. Anecdotal reports suggest that flubromazepam leans more towards sedative and anxiolytic effects, making it appealing for those seeking relief from anxiety and stress.
Flubromazepam is recognized for its long-lasting psychoactive effects, which include:
Despite its potential benefits, the exact pharmacological activities of flubromazepam remain largely unverified due to the lack of formal studies. Existing literature suggests that it may possess significant anxiolytic and sedative properties, but caution is warranted given the limited understanding of its full effects.
As with many benzodiazepines, flubromazepam carries risks, particularly concerning dependency and withdrawal symptoms. Its long half-life may lead to prolonged effects, which can be both beneficial and detrimental. Users should be aware of the potential for tolerance, dependence, and adverse reactions, especially when combined with other depressants.
Flubromazepam's journey from obscurity to a substance of interest in the designer drug community highlights the complexities of drug development and the evolving landscape of psychoactive substances. While it shows promise as a long-acting benzodiazepine with various therapeutic effects, the lack of formal research necessitates caution. As interest in flubromazepam continues to grow, further studies are essential to fully understand its pharmacological profile, safety, and potential applications in medicine.
Flubromazepam 8mg Pellets is for research use only and not intended for human consumption!
Flubromazepam 8mg Pellets stock last updated at: April 2025